ACK (Ammonium-Chloride-Potassium) Lysing Buffer is used for the lysis of red blood cells in samples containing white blood cells, suchLeia mais
Have Questions?
Número do catálogo
Quantity
A1049201
100 mL
Número do catálogo A1049201
Preço (BRL)
175,60
Each
Adicionar ao carrinho
Quantity:
100 mL
Preço (BRL)
175,60
Each
Adicionar ao carrinho
ACK (Ammonium-Chloride-Potassium) Lysing Buffer is used for the lysis of red blood cells in samples containing white blood cells, such as EDTA-treated whole blood, buffy coats, and bone marrow. The complete formulation and lysis protocol are available in our Technical Reference Library.
cGMP manufacturing and quality system ACK Lysing Buffer is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
For Research Use Only. Not for use in diagnostic procedures.
Especificações
Chemical Name or MaterialLysing Buffer
Recommended StorageStorage conditions: 15–30°C. Protect from light. Shipping conditions: ambient Shelf life: 12 months from date of manufacture
Shelf Life12 Months
SterilitySterile
Physical FormLiquid
Product LineGibco
Quantity100 mL
Unit SizeEach
Frequently asked questions (FAQs)
What alternative do you offer for ACK Lysing Buffer (Cat. No. A1049201)?
Alternative products we offer are eBioscience 1X RBC Lysis Buffer (Cat. No. 00-4333-57) or eBioscience 10X RBC Lysis Buffer (Multi-species) (Cat. No. 00-4300-54).
Can I use ACK Lysing Buffer with heparinized blood?
Yes, ACK Lysing Buffer can be used with heparinized blood. The principle of lysis is osmotic treatment.
Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines.
Authors:Avci FY, Li X, Tsuji M, Kasper DL,
Journal:Nat Protoc
PubMed ID:23196974
Here we describe how to isolate carbohydrate-specific T cell clones (for which we propose the designation 'Tcarbs') after stimulation by two glycoconjugate vaccines. We describe how to prepare, purify and characterize two model glycoconjugate vaccines that can be used to generate Tcarbs. These glycoconjugate vaccines (GBSIII-OVA and GBSIII-TT) are synthesized ... More